Promising Alzheimer's drug candidate prevents buildup of tau proteins in lab and fruit fly studies
An international team of researchers led by Lancaster University has made a promising breakthrough in the development of ...
Alzheimer’s Game Changer: Dual-Action Drug Attacks Disease at Its Core
AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.
Neuroscience News7h
Dual-Targeting Drug Halts Tau Accumulation in Alzheimer’s
Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...
‘One-of-a-kind’ new Alzheimer’s drug shows promise: ‘An exciting development’
“This research is taking promising steps towards a new one-of-a-kind therapy which targets tau, a damaging protein in the ...
Science Daily8h
Promising 'First' in Alzheimer's drug development
An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease. For the first time, scientists have developed a drug that works on ...
Daijiworld13h
New Alzheimer’s drug shows promise to prevent buildup of tau proteins in brain cells
In a promising breakthrough, an international team of researchers from the UK, US, and Japan has developed a new Alzheimer’s drug that effectively prevents the build-up of Tau proteins -- a key driver ...
Promising New Alzheimer’s Treatment Eradicates Tau Tangles
Innovative treatments using TRIM21 have successfully targeted tau aggregates in Alzheimer’s, showing potential for broader ...
Alzheimer’s breakthrough after drug treatment success
Alzheimer’s breakthrough after drug treatment success - Study found that the medication, called RI-AG03, was effective at ...
Breakthrough Alzheimer’s Drug Prevents Toxic Protein Build-up In Brain
Researchers from a study funded by the Alzheimer’s Society of UK have developed a new drug known as RI-AG03 that they say can ...
BioTechniques9d
Novel tau therapies show promise for Alzheimer’s
Two new therapies have successfully cleared tau aggregates in preclinical and mouse models, showing potential as dementia ...